MDM2 inhibitor APG-115 exerts potent antitumor activity and synergizes with standard-of-care agents in preclinical acute myeloid leukemia models

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous clonal disease associated with unmet medical needs. Paralleling the pathology of other cancers, AML tumorigenesis and propagation can be ascribed to dysregulated cellular processes, including apoptosis. This function and othe...

Descripción completa

Detalles Bibliográficos
Autores principales: Fang, Douglas D., Tang, Qiuqiong, Kong, Yanhui, Rong, Tao, Wang, Qixin, Li, Na, Fang, Xu, Gu, Jiaxing, Xiong, Dengkun, Yin, Yan, Deng, Jing, Yang, Dajun, Zhai, Yifan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8093284/
https://www.ncbi.nlm.nih.gov/pubmed/33941774
http://dx.doi.org/10.1038/s41420-021-00465-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8093284/
https://www.ncbi.nlm.nih.gov/pubmed/33941774
http://dx.doi.org/10.1038/s41420-021-00465-5

Ejemplares similares